|
1
|
Leung DW, Cachianes G, Kuang WJ, Goeddel
DV and Ferrara N: Vascular endothelial growth factor is a secreted
angiogenic mitogen. Science. 246:1306–1309. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Breen EC: VEGF in biological control. J
Cell Biochem. 102:1358–1367. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carmeliet P: Angiogenesis in health and
disease. Nat Med. 9:653–660. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carmeliet P: VEGF as a key mediator of
angiogenesis in cancer. Oncology. 69(Suppl 3): 4–10. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clauss M: Molecular biology of the VEGF
and the VEGF receptor family. Semin Thromb Hemost. 26:561–569.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Claesson-Welsh L and Welsh M: VEGFA and
tumour angiogenesis. J Intern Med. 273:114–127. 2013. View Article : Google Scholar
|
|
8
|
Geng L, Chaudhuri A, Talmon G, Wisecarver
JL and Wang J: TGF-Beta suppresses VEGFA-mediated angiogenesis in
colon cancer metastasis. PLoS One. 8:e599182013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen K, Ji L, Lu B and Wang Z: c-Jun
N-terminal kinase mediated VEGFR2 sustained phosphorylation is
critical for VEGFA-induced angiogenesis in vitro and in vivo. Cell
Biochem Biophys. 64:17–27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Weijts BG, Bakker WJ, Cornelissen PW,
Liang KH, et al: E2F7 and E2F8 promote angiogenesis through
transcriptional activation of VEGFA in cooperation with HIF1. EMBO
J. 31:3871–3884. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shibuya M, Yamaguchi S, Yamane A, Ikeda T,
Tojo A, Matsushime H and Sato M: Nucleotide sequence and expression
of a novel human receptor-type tyrosine kinase gene (flt) closely
related to the fms family. Oncogene. 5:519–524. 1990.PubMed/NCBI
|
|
12
|
Terman BI, Carrion ME, Kovacs E, Rasmussen
BA, Eddy RL and Shows TB: Identification of a new endothelial cell
growth factor receptor tyrosine kinase. Oncogene. 6:1677–1683.
1991.PubMed/NCBI
|
|
13
|
Wiesmann C, Fuh G, Christinger HW, et al:
Crystal structure at 1.7 A resolution of VEGF in complex with
domain 2 of the Flt-1 receptor. Cell. 91:695–704. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park JE, Chen HH, Winer J, Houck KA and
Ferrara N: Placenta growth factor. Potentiation of vascular
endothelial growth factor bioactivity, in vitro and in vivo, and
high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem.
269:25646–25654. 1994.PubMed/NCBI
|
|
15
|
Ejima D, Yumioka R, Tsumoto K and Arakawa
T: Effective elution of antibodies by arginine and arginine
derivatives in affnity column chromatography. Anal Biochem.
345:250–257. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arakawa T, Philo JS, Tsumoto K, et al:
Elution of antibodies from a Protein-A column by aqueous arginine
solutions. Protein Expr Purif. 36:244–248. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi ML, Duan HF, Xu ZP, Hu XW and Chen HP:
Optimization of applying chick chorioallantoic membrane to
angiogenesis assay. Letters in Biotech. 19:566–568. 2008.(In
Chinese).
|
|
18
|
Herley MT, Yu Y, Whitney RG and Sato JD:
Characterization of the VEGF binding site on the Flt-1 receptor.
Biochem Biophys Res Commun. 262:731–738. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Holash J, Davis S, Papadopoulos N, et al:
VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl
Acad Sci USA. 99:11393–11398. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guedez L, Rivera AM, Salloum R, et al:
Quantitative assessment of angiogenic response by the directed in
vivo angiogenesis assay. Am J Pathol. 162:1431–1439. 2003.
View Article : Google Scholar : PubMed/NCBI
|
